Signal Path enhances clinical research by dramatically improving the ease and efficiency of trial execution and management by combining a network of premier, technology-enabled research sites with a best-in-class suite of clinical trial tools to reduce complexity experienced by sites and sponsors. The company’s clinical trial management system (CTMS) digitizes protocols for clients, which eliminates a significant impediment to utilization, ensures quality of trial execution, drives efficiencies and enables site staff to focus on patients.
![](https://highlander-partners.com/wp-content/uploads/2021/08/portfolio_signalpath.jpg)
Signal Path
Raleigh, North Carolina, USA
Investment Date:
April 2015
Exit Date:
August 2021
www.signalpath.com